To this end, we compared the tumor transcriptomic profiles of breast tumors from patients with ER+/HER2− (which is the most frequent breast cancer subtype) dnMBC and pair-wise matched breast tumors from patients with eBC. This evidence concerns the gene ESR1 and neoplasm.